Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptors in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 491-501

  Bilsky, Edward J ^a   Bernstein, Robert N ^a   Hruby, Victor J ^a   Rothman, Richard B ^b   Lai, Josephine ^a   Porreca, Frank ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b NIDA Addiction Research Center   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; HYPOTHESIS; LIGAND BINDING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; TAIL FLICK TEST;

ANALGESICS; ANIMALS; BASE SEQUENCE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; GTP-BINDING PROTEINS; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; RECEPTORS, OPIOID, DELTA;

EID: 0030424478     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. 4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Life Sci. 55: PL37-PL43, 1994.
2. 6]enkephalin: Covalent attachment via thiol-disulfide exchange. J. Biol. Chem. 262: 13434-13439, 1987.
3. BUZAS, B., IZENWASSER, S., PORTOGHESE, P. S. AND COX, B. M.: Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sci. 54: PL101-PL106, 1994.
4. CHA, X. Y., XU, H., RICE, K. C., PORRECA, F., LAI, J., ANANTHAN, S. AND ROTHMAN, R. B.: Opioid peptide receptor studies. 1. Identification of a novel d opioid receptor binding site in rat brain membranes. Peptides 16: 191-198, 1995.
5. CHEN, Y., MESICK, A., LIU, J., HURLEY, A. AND YU, L.: Molecular cloning and functional expression of a mu opioid receptor from rat brain. Mol. Pharmacol. 44: 8-12, 1993.
6. 3H]NALTRINDOLE: a potent and selective ligand for labelling delta-opioid receptors. Brain Res. 604: 160-164, 1993.
7. COTTON, R., GILES, M. G., MILLER, L., SHAW, J. S. AND TIMMS, D.: ICI 174864: A highly selective antagonist for the opioid δ-receptor. Eur. J. Pharmacol. 97: 331-332, 1984.
8. EVANS, C. J., KEITH, J., D. E., MORRISON, H., MAGENDOZA, K. AND EDWARDS, R. H.: Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955, 1992.
9. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, G., NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. AND KREIL, G.: Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A. 86: 5188-5192, 1989.
10. 3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: Evidence for delta opioid receptor heterogeneity. J. Pharmacol. Exp. Ther. 268: 836-846, 1994.
11. 2 and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J. Neurosci. 14: 4965-4971, 1994.
12. HEYMAN, J. S , MULVANEY, S. A., MOSBERG, H. I. AND PORRECA, F.: Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420: 100-108, 1987.
13. JANSSEN, P. A. J., NIEMEGEERS, C. J. E. AND DONY, J. G. H.: The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneim. Forsch. 13: 502-507, 1963.
14. 2]deltorphin II, a highly selective δ agonist in vivo. Life Sci. 47: P143-P147, 1990a.
15. 6]enkephalin J. Pharmacol. and Exp. Ther. 255: 636-641, 1990b.
16. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257: 1069-1075, 1991.
17. KIEFFER, B. L., BEFORT, K., GAVERIAUX-RUFF, C. AND HIRTH, C. G.: The delta opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. 89: 12048-12052, 1992.
18. 2-agonist antinociception. NeuroReport 5: 1049-1052, 1994.
19. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258: 583-587, 1991.
20. MATTIA, A., FARMER, S. C., TAKEMORI, A. E., SULTANA, M., PORTOGHESE, P. S., MOSBERG, H I., BOWEN, W. D. AND PORRECA, F.: Spinal opioid delta antinociception in the mouse: Mediation by a 5′-NTII-sensitive delta receptor subtype. J. Pharmacol. Exp. Ther. 260: 518-525, 1992.
21. MINAMI, M., TOYA, T., KATAO, Y., MAEKAWA, K., NAKAMURA, S., ONOGI, T., KANEKO, S. AND SATOH, M.: Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329: 291-295, 1993.
22. MISICKA, A., LIPKOWSKI, W. W., FANG, L., KNAPP, R. J., DAVIS, P., KRAMER, T , BURKS, T. F., YAMAMURA, H. I., CARR, D. B. AND HRUBY, V. J.: Topographical requirements for d opioid ligands: Presence of a carboxyl group in position 4 is not critical for deltorphin's high delta receptor affinity and analgesic activity. Biochem. Biophysic. Res. Commun. 180: 1290-1297, 1991.
23. MOKHTARI, M., TAFANI, J. A. AND ZAJAC, J. M.: Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography. Neuropeptides 25: 183-191, 1993.
24. MOSBERG, H. I., HURST, R., HRUBY, V. J., GEE, K., AKIYAMA, K., YAMAMURA, H I., GALLIGAN, J. J. AND BURKS, T. F.: Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities. Life Sci. 33: 447-450, 1983.
25. PORRECA, F., MOSBERG, H. I., HURST, R., HRUBY, V. J. AND BURKS, T. F.: Roles of μ, δ and κ opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J. Pharmacol. Exp. Ther. 230: 341-348, 1984.
26. PORTOGHESE, P. S., SULTANA, M. AND TAKEMORI, A. E.: Naltrindole 5′-isothiocyanate: A nonequilibrium, highly selective δ opioid receptor antagonist. J. Med. Chem. 33: 1547-1548, 1990.
27. 1 opioid receptor antagonist: 7-Benzylidenenaltrexone. Eur. J. Pharmacol. 218: 195-196, 1992.
28. SOFUOGLU, M., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257: 676-680, 1991.
29. STANDIFER, K. M., CHIEN, C-C., WAHLESTEDT, C., BROWN, G. P. AND PASTERNAK, G. W : Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12: 805-810, 1994.
30. 4]deltorphin. J. Pharmacol. Exp. Ther. 266: 820-828, 1993.
31. TALLARIDA, R. J. AND MURRAY, R B.: Mannual of Pharmacological Calculations, 2nd ed., Springer-Verlag, New York, 1986.
32. TISEO, P. J. AND YAKSH, T. L.: Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: Additional evidence for δ-opioid receptor subtypes in the rat. Eur. J. Pharmacol. 236: 89-96, 1993.
33. TSENG, L., COLLINS, K. A. AND KAMPINE, J. P.: Antisense oligodeoxynucleotide to a δ opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258: R1-R3, 1994.
34. 4]deltorphin with delta-opioid receptor subtypes in vivo. Eur. J. Pharmacol. 252: 133-137, 1994.
35. WAHLESTEDT, C , GOLANOV, E., YAMAMOTO, S., YEE, F., ERICSON, H., YOO, H , INTURRISI, C. E. AND REIS, D. J.: Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363: 260-263, 1993a.
36. WAHLESTEDT, C., PICH, E. M., KOOB, G. F., YEE, F. AND HEILIG, M.: Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259: 528-531, 1993b.
37. WAHLESTEDT, C.: Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15: 42-46, 1994.
38. WATSON, G. B. AND LANTHORN, T. H.: Electrophysiological actions of delta opioids in CA1 of the rat hippocampal slice are mediated by one delta receptor subtype. Brain Res. 601: 129-135, 1993.
39. WILD, K. D., FANG, L., MCNUTT, R. W., CHANG, K. J., TOTH, G., BORSODI, A , YAMAMURA, H. I. AND PORRECA, F.: Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium. Eur. J. Pharmacol. Mol. Pharmacol. Section 246: 289-292, 1993.
40. 3H]naltrindole binding to delta opioid receptors in rat brain. Life Sci. 50: PL119-PL124, 1992.
41. YASUBA, K., RAYNOR, K., KONG, H., BREDER, C., TAKEDA, J., REISINE, T. AND BELL, G. I.: Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Nat. Acad. Sci. U.S.A. 90: 6736-6740, 1993.
42. ncx binding sites in rat brain: Further evidence for heterogenity. Peptides 13: 1207-1213, 1992.
43. ncx binding sites in mouse brain: Further evidence for δ receptor heterogeneity. Peptides 14: 893-907, 1993.
44. ZHOU, L-W., ZHANG, S-P., QIN, Z-H. AND WEISS, B.: In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. J. Pharmacol. Exp. Ther. 268: 1015-1023, 1994.